Kara Stancell
Contatto Relazioni con gli Investitori presso CLARUS THERAPEUTICS HOLDINGS, INC.
Profilo
Kara J.
Stancell is currently the VP-Investor Relations & Corporate Communications at Clarus Therapeutics Holdings, Inc. She previously worked as the Executive Director-Investor Relations at Medicis Pharmaceutical Corp.
from 2010 to 2011 and as the VP-Investor Relations & Corporate Communications at Dermavant Sciences, Inc. from 2018 to 2021.
Posizioni attive di Kara Stancell
| Società | Posizione | Inizio |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Kara Stancell
| Società | Posizione | Fine |
|---|---|---|
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Contatto Relazioni con gli Investitori | 01/03/2021 |
| MEDICIS PHARMACEUTICAL CORP | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
- Borsa valori
- Insiders
- Kara Stancell